Ledipasvir/Sofosbuvir plus Ribavirin (LDV/SOF+RBV) for 12 Weeks in Decompensated HCV Genotype 1 Patients: SOLAR-1 and-2 Studies Compared to a Real-World Dataset

Volume
64
Pagination
489A - 490A
ISSN
0270-9139
Metadata
Show full item record
Authors
Charlton, MR; Cheung, MC; Manns, MP; Sajed, N; Troke, P; Spellman, JG; Copans, A; Arterburn, S; Brainard, DM; Irving, W
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/23495
Collections